Fig. 1From: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)Study schema. Subjects who meet eligibility criteria and qualify for enrolment will be randomized as demonstratedBack to article page